Meta-Analysis of clinical features of Systemic Lupus Erythematosus with and without Antiphospholipid

来源 :2016年第18届亚太风湿病协会联盟大会(APLAP) | 被引量 : 0次 | 上传用户:wangdalu
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background:Systemic lupus erythematosus(SLE)is a chronic autoimmune multiorgan disease of unknown etiology.Antiphospholipid Syndrome(APS)is an autoimmune disorder characterised by the presence of antiphospholipid antibodies and a state of hypercoagulability with increased tendency to thrombotic events and obstetric morbidity.The polyautoimmuntity of APS and SLE is a reflection of complex disease traits.However,there have not been many studies addressing this issue,especially its implications in relation to optimal treatment.Objective:We aim to compare the clinical manifestations in SLE patients with and without APS for an early disease diagnosis.Methods:Medline and Embase databases have been searched for studies comparing SLE patients with and without APS and clinical manifestations were considered as the endpoints.A fixed effect model has been used where a small heterogeneity was observed.Odd Ratio(OR)with 95%confidence interval(CI)was used to express the pooled effect on dichotomous variables and the pooled analyses were performed with RevMan 5·3.Results:This meta-analysis included eleven studies consisting of a total of 1990 SLE patients(330 patients with APS and 1660 without APS).Cardiovascular manifestations,obstetric morbidities and venous thrombosis were significantly higher in SLE patients with APS with OR:2.56,95%CI:1.37 – 4.76; P = 0.003; OR:14.30,95%CI:7.98 – 25.63; P < 0.00001 and OR:13.62,95%CI:6.96 – 26.63; P < 0.00001 respectively.Conclusion:Coexistence of APS with SLE gives rise to a higher rate of thromboembolic events and obstetric morbities and adversely impacts the cardiovascular manifestations.
其他文献
会议
会议
会议
会议
会议
Background:Cardiovascular events occur with earlier onset in patients with SLE compared with healthy individuals.The evaluation of Carotid Intimal-Media Thickness(cIMT)has recently became one of the s
Background:Thrombotic event is one of mortality cause in SLE patients beside infection and disease activity.Thrombotic risk factors in SLE consist of antiphospholipid syndrome,accelerated atherosclero
Background:The advancement of Systemic Lupus Erythematosus(SLE)treatment has increased the survival of SLE patients.Thus,quality of life(QoL)has become an important aspect in evaluating SLE therapy in
会议
会议